Cell therapy collaboration with leading global life science company continues to expand
In January 2023, AcouSort reported that the company’s collaboration with a global life science company active within the cell therapy field had been extended with a second phase. The second phase of the collaboration has been brought to a successful close and the partnering company has now ordered an evaluation setup to internally assess the potential of AcouSort’s technology. The new activity will generate additional revenues of EUR 50 000 in 2023.
Read the full press release here.
Läs pressmeddelandet på svenska här.